87
Participants
Start Date
September 30, 2004
Primary Completion Date
March 31, 2007
Study Completion Date
March 31, 2007
Levetiracetam
Oral tablets or oral solution at 20-60 mg/kg/d, divided into twice daily dosing.
Placebo (PB)
Oral tablets and oral solution
Birmingham
Phoenix
Tucson
Little Rock
La Jolla
Los Angeles
Denver
Washington D.C.
Bradenton
Gainesville
Loxahatchee Groves
Miami
Orlando
Tallahassee
Tampa
Atlanta
Augusta
Chicago
Voorhees Township
Buffalo
New York
Rochester
Winston-Salem
Cleveland
Hershey
Philadelphia
Pittsburgh
Charleston
Germantown
Dallas
Fort Worth
Galveston
Houston
Norfolk
Richmond
Seattle
Morgantown
Milwaukee
Scarborough Village
Thornhill
Toronto
Bloemfontein
Cape Town
Capitol Park
Johannesburg
Lead Sponsor
UCB Pharma
INDUSTRY